206
Participants
Start Date
June 30, 2022
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
GP+DDP
Gemcitabine as induction chemotherapy, 1000 mg/m2 day 1, 8 per cycle, every 3 weeks for 3 cycles; induction cisplatin 80mg/m2, every 3 weeks for 3 cycles before radiation; concurrent cisplatin 100mg/m2, every 3 weeks for 2 cycles during radiation
Palbociclib
Administered orally
Intensity-modulated radiotherapy
Definitive IMRT of 70 Gy, 33 fractions, 5 fractions/week, 1 fraction/day
PD-1 blocking antibody
Administered every 3 weeks
Galunisertib
Administered orally
Sun Yat-sen University Cancer Center, Guangzhou
Sun Yat-sen University
OTHER